Episode Details
Back to Episodes
DiagnosTear Expands to India: A New Era for Ocular Diagnostics | DiagnosTear Technologies (CSE: DTR) | The Watchlist E61
Description
DiagnosTear Technologies (CSE: DTR) is taking a major step toward global growth with a new Letter of Intent to bring its TeaRx™ ocular diagnostics platform to India. The TeaRx™ system analyzes biomarkers in tears, providing physicians with rapid, non-invasive insights into eye health — a breakthrough that could redefine the diagnosis and treatment of dry eye and other ocular diseases.
In this episode, listeners will hear:
How DiagnosTear’s TeaRx™ technology detects and classifies eye conditions
Why tear-based biomarkers could revolutionize patient-specific care
The strategic importance of expanding into India’s healthcare market
What’s next for DiagnosTear’s global commercialization
Website: https://diagnostear.com
Disclaimer: This podcast is made in partnership with DiagnosTear Technologies. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://themarketonline.ca/disclaimer
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.